Back
BOK Financial Vs. Neurogene Industry Stock Comparison
Buy
57
BOKF
BOK Financial
Last Price:
115.02
Seasonality Move:
0.52%
Sell
5
NGNE
Neurogene
Last Price:
40.09
Seasonality Move:
50.43%
Buy
57
BOK Financial (BOKF)
is a Buy
Is BOK Financial a Buy, Sell or Hold?
- The current BOK Financial [BOKF] share price is $115.77. The Score for BOKF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- BOKF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
5
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BOKF Stock Price Chart
What is BOK Financial's stock price today?
-
The BOK Financial share price today is $115.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BOKF is experiencing selling pressure, which indicates risk of future bearish movement.
BOKF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.58 | Buy |
| Relative Strength Index (14 RSI): | 59.9 | Buy |
| Chaikin Money Flow: | -158522 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (106.04 - 114.54) | Buy |
| Bollinger Bands (100): | (96.1 - 109.4) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.3 | Buy |
| Relative Strength Index (14 RSI): | 39.1 | Sell |
| Chaikin Money Flow: | -346626 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.29 - 61.53) | Sell |
| Bollinger Bands (100): | (34.11 - 50.51) | Sell |
BOKF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 113.58 | Buy |
| 20-day SMA: | 110.55 | Buy |
| 50-day SMA: | 106.87 | Buy |
| 200-day SMA: | 95.51 | Buy |
| 8-day EMA: | 114.07 | Buy |
| 20-day EMA: | 111.11 | Buy |
| 50-day EMA: | 107.51 | Buy |
| 200-day EMA: | 97.73 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.39 | Sell |
| 20-day SMA: | 53.17 | Sell |
| 50-day SMA: | 46.66 | Sell |
| 200-day SMA: | 38.93 | Buy |
| 8-day EMA: | 54.03 | Sell |
| 20-day EMA: | 53.18 | Sell |
| 50-day EMA: | 48.36 | Sell |
| 200-day EMA: | 38.47 | Buy |
BOK Financial Earnings Growth & BOKF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and an increase next year of $0.49 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
BOK Financial Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||